$PLPL - Plandai Vice President, Jamen Shively,

$PLPL - Plandai Vice President, Jamen Shively, stated, "As one of the few companies out there with a vested interest in medicinal cannabis research, and the stated goal of furthering such research, we see ourselves as duty-bound to help craft legislation and to support those institutions that are paving the way in this emerging field. The medical cannabis industry has been surviving solely on anecdotal evidence and limited medical research for too long. It is time to invest in legitimate, double blind human studies to confirm the effectiveness of cannabis therapy for not only cancers but also neural diseases such as Parkinson's, Alzheimer's, MS, PTSD and epilepsy. We applaud Mr. Oriani-Ambrosini for his pioneering legislation and look forward to doing our part in not only supporting his efforts but also funding research in South Africa if the bill eventually passes."